A Double-Blind, Randomized, Placebo-Controlled, 2-Way Cross-Over Study to Evaluate the Effect of Single Dose Canagliflozin on Kinetics of C-Peptide in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2015
At a glance
- Drugs C-peptide (Primary) ; Canagliflozin (Primary) ; Somatostatin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Janssen-Cilag
- 23 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2012 Planned End Date changed from 1 Sep 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.